• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

New Apple Watch App Uses Algorithm to Detect Seizures & Alert Providers

by Jasmine Pennic 01/26/2018 1 Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

New Apple Watch App Uses Algorithm to Detect Seizures & Alert Providers

Smart Monitor, a Silicon Valley, CA-based provider of clinically validated solutions for the management of complex chronic conditions has announced the launch of SmartWatch Inspyre for the Apple Watch.  The new Apple Watch app uses a unique algorithm to recognize a wearer’s repetitive shaking movements, similar to those caused by convulsive seizures.

Designated family members and care providers are alerted upon onset of these movement patterns so they can intervene in a timely manner to maximize safety of their loved one. The episodic data is captured in a secure HIPAA-compliant cloud for review and analysis. 

SmartWatch Inspyre users can also summon help with the push of a button. Alerts can be sent to any phone, anywhere, and detailed reports of each event can be securely accessed for later review with physicians.

Family members appreciate the peace-of-mind, especially at night knowing they can be on hand to provide assistance when needed. Furthermore, users and caregivers alike value that the activity reports can be downloaded at any time for thorough analysis.

Clinical Studies

The SmartWatch Inspyre by Smart Monitor has undergone clinical studies at top medical institutions across adult and pediatric populations that validates its ability to alert upon repetitive shaking motion. Studies at Stanford with 40 adult participants were concluded in June 2010. SmartWatch Inspyre performed with very high sensitivity – in the high 90s as noted in the journal article: Lockman J, Fisher RS, Olson DM. Detection of seizure-like movements using a wrist accelerometer. Epilepsy and Behavior 2011; 20:638-41. Studies at the University of California, San Francisco with the pediatric population were completed in 2013. The device has been used on children as young as 3 years old. In over 500 hours of testing, the device sensitivity in detecting tonic-clonic seizures was 100%; device specificity was over 90%.

“We are pleased to be able to offer Inspyre on the Apple Watch,” said Anoo Nathan, CEO in a statemnet. “This really is a game changer for patients and families alike. Inspyre enhances the safety and autonomy of people prone to seizures while providing peace of mind for families and loved ones.

SmartWatch Inspyre by Smart Monitor is currently being used in clinical studies at Stanford University, NYU Langone Medical Center, Boston Children’s Hospital and the University of Virginia. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Apple Watch, Apple Watch App, seizures, Smart Monitor

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |